CAPLIPOINT

Caplin Point Laboratories Share Price

 

 

Invest in Caplin Point Laboratories with 3.02X leverage

Invest with MTF

Performance

  • Low
  • ₹1,805
  • High
  • ₹1,837
  • 52 Week Low
  • ₹1,599
  • 52 Week High
  • ₹2,405
  • Open Price₹1,812
  • Previous Close₹1,803
  • Volume47,882
  • 50 DMA₹1,913.66
  • 100 DMA₹1,966.04
  • 200 DMA₹1,987.01

Investment Returns

  • Over 1 Month -7.73%
  • Over 3 Month -11.9%
  • Over 6 Month -10.44%
  • Over 1 Year -23.64%

Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!

Invest Now

Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 23.4
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 13,774
  • P/B Ratio
  • 4.4
  • Average True Range
  • 50.82
  • EPS
  • 77.46
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -28.65
  • RSI
  • 40.04
  • MFI
  • 24.83

Caplin Point Laboratories Financials

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹1,812.10
+ 8.7 (0.48%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹1,860.52
  • 50 Day
  • ₹1,913.66
  • 100 Day
  • ₹1,966.04
  • 200 Day
  • ₹1,987.01

Resistance and Support

1818 Pivot Speed
  • R3 1,862.90
  • R2 1,849.90
  • R1 1,831.00
  • S1 1,799.10
  • S2 1,786.10
  • S3 1,767.20

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Caplin Point Laboratories is a rapidly growing pharmaceutical company with a strong presence in Latin America, Francophone Africa, and expanding into regulated markets like the USA and EU. it specializes in manufacturing and distributing a wide range of pharmaceutical products.

Caplin Point Labs. has an operating revenue of Rs. 2,039.67 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 35% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-05 Quarterly Results
2025-08-07 Quarterly Results, Final Dividend & A.G.M.
2025-05-15 Audited Results & Interim Dividend
2025-02-07 Quarterly Results
2024-11-07 Quarterly Results
Date Purpose Remarks
2025-09-12 FINAL Rs.3.00 per share(150%)Final Dividend
2025-05-30 INTERIM Rs.3.00 per share(150%)Interim Dividend
2024-05-31 INTERIM Rs.2.50 per share(125%)Interim Dividend
2023-06-09 INTERIM Rs.2.00 per share(100%)Interim Dividend
2022-05-24 INTERIM Rs.2.00 per share(100%)Interim Dividend
View Caplin Point Laboratories Dividend History Arrow

Caplin Point Laboratories F&O

Caplin Point Laboratories Shareholding Pattern

70.57%
1.79%
0.23%
6.51%
0%
14.2%
6.7%

About Caplin Point Laboratories

  • NSE Symbol
  • CAPLIPOINT
  • BSE Symbol
  • 524742
  • Managing Director
  • Dr. Sridhar Ganesan
  • ISIN
  • INE475E01026

Similar Stocks to Caplin Point Laboratories

Caplin Point Laboratories FAQs

Caplin Point Laboratories share price is ₹1,812 As on 13 January, 2026 | 20:15

The Market Cap of Caplin Point Laboratories is ₹13774.1 Cr As on 13 January, 2026 | 20:15

The P/E ratio of Caplin Point Laboratories is 23.4 As on 13 January, 2026 | 20:15

The PB ratio of Caplin Point Laboratories is 4.4 As on 13 January, 2026 | 20:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23